A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
HuMax-CD20 in Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients
- Status
- COMPLETED
- Phase
- PHASE3
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- NA
A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1